Patients newly diagnosed with IPF at the time of a respiratory-related hospitalization had significantly shorter survival.

Calluna Pharma Completes Enrollment in Phase 2 AURORA Study of CAL101 for IPF, six months ahead of plan with topline expected ...

The randomized Phase 2b ASPIRE trial successfully completed planned enrollment of over 360 patients, reflecting strong execution and robust site engagement ASPIRE is designed to assess the effect of ...

At the end of this month, the Association of Real Estate Funds (AREF), the British Property Federation (BPF) and the ...

An independent think tank on policing has called for a multi-agency investigation into the recent unearthing of a spurious ...

HIGHLIGHTSMature data from Amplia’s ACCENT trial in pancreatic cancer is being presented at the prestigious American Association of Cancer ...

Pollo AI today announced the availability of OpenAI's GPT Image 2 on its platform, giving creators, marketers, and businesses access to a stronger image model for work that depends on getting details ...

C-Infinity, the AI platform that automates how digital designs are translated into production-ready plans, today announced it has raised $16 million in funding led by Canaan Partners, with ...

Target identification is the first and perhaps most critical step in drug discovery and development. Although the human genome contains roughly 20,000 protein-coding genes, only about 4,500 are ...

DifGen Pharmaceuticals shared that its partner, Apotex recently received approval from the Food and Drug Administration for nintedanib soft gel capsules, 100 mg and 150 mg, which is the generic of ...

Abnormalities in DNA methylation, a genetic modification, may affect disease risk in idiopathic pulmonary fibrosis, according ...